Management of Stage 2 Acute Kidney Injury
Stage 2 AKI requires immediate withdrawal of diuretics, discontinuation of all nephrotoxic agents, and plasma volume expansion with intravenous albumin at 1 g/kg body weight, with close monitoring for progression to stage 3 or regression to stage 1. 1
Immediate Actions (Within 12 Hours)
1. Medication Review and Adjustment
- Stop all diuretics immediately if not already done 1
- Discontinue nephrotoxic drugs: NSAIDs, aminoglycosides, acyclovir, VEGF antagonists 2
- Hold ACE inhibitors and ARBs in the acute setting 2
- Avoid vasodilators that may compromise renal perfusion 1
- Review all over-the-counter medications 1
2. Hemodynamic Optimization
- Maintain MAP >65 mmHg using vasopressors if needed 2, 3
- Use isotonic crystalloids (not colloids or hydroxyethyl starch) for volume expansion 4, 5
- Consider balanced crystalloid solutions over 0.9% saline to reduce risk of further kidney injury 2
- In cirrhotic patients specifically: IV albumin 1 g/kg body weight for plasma volume expansion 1
3. Monitoring Protocol
- Serial serum creatinine measurements every 12-24 hours to assess progression or regression 2
- Hourly urine output monitoring 2, 3
- Daily assessment of fluid balance - avoid fluid overload which creates a vicious cycle 2
- Monitor for progression to stage 3 (creatinine >3x baseline or ≥4.0 mg/dL) 1, 6
Risk Stratification
Stage 2 AKI patients are at significantly higher risk than stage 1:
- 20% hospital mortality vs 1% in stage 1 7
- 44% 30-day transplant-free mortality vs 19% in stage 1 7
- Higher likelihood of requiring dialysis and ICU admission 7
Key predictors of progression to stage 3:
- Baseline creatinine ≥1.5 mg/dL (133 μmol/L) 6
- Presence of systemic inflammatory response syndrome 7
- Development of second nosocomial infection 7
- Higher MELD scores in cirrhotic patients 7
Context-Specific Considerations
In Cirrhosis with Ascites
The evidence is strongest here: albumin infusion is the cornerstone of treatment for stage 2 AKI 1. These patients have worse outcomes with stage 2-3 AKI (80% hospital survival vs 99% in stage 1) 7.
In Critical Illness
Implement the complete kidney protection strategy within 12 hours 3:
- Hemodynamic monitoring with MAP optimization
- Sustained MAP >65 mmHg for 48 hours
- Avoidance of hyperglycemia
- Strict avoidance of radiocontrast agents when possible
- Full KPS adherence increases renal recovery 6-fold 3
When to Escalate to RRT
Consider renal replacement therapy if:
- Progression to stage 3 despite interventions 2
- Development of fluid overload refractory to medical management 2
- Severe metabolic acidosis 2
- Uremic complications
- Continuous RRT preferred in hemodynamically unstable patients 2, 5
Critical Pitfalls to Avoid
- Do not attempt aggressive fluid resuscitation to "reverse" established stage 2 AKI - this leads to fluid overload without benefit 2
- Oliguria has multiple etiologies beyond hypovolemia - do not reflexively give fluids 2
- Avoid hydroxyethyl starch - associated with increased RRT need and mortality 5
- Do not use colloids (including albumin in non-cirrhotic patients) for initial volume expansion 4
- Stage 2 is not "mild" - it carries substantial mortality risk and requires intensive monitoring 7
Follow-up After Recovery
- Assess kidney function at 3 months post-discharge 4, 8
- Monitor for development of CKD (35% GFR decrease or >50% creatinine increase) 2
- Check urine albumin-to-creatinine ratio 8
- Optimize cardiovascular risk factors 8
- Consider RAAS inhibitors and SGLT2 inhibitors after recovery 8
The key distinction: Stage 2 AKI is a medical emergency requiring immediate, aggressive supportive care focused on hemodynamic optimization, nephrotoxin avoidance, and close monitoring - not a condition amenable to "wait and see" management.